Journal
FASEB JOURNAL
Volume 32, Issue 2, Pages 862-874Publisher
FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.201700555R
Keywords
airway smooth muscle; asthma; biased agonism; GPR68; qualitative signaling
Categories
Funding
- U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute [P01 HL114471, HL087560]
Ask authors/readers for more resources
GPCRs have diverse signaling capabilities, based on their ability to assume various conformations. Moreover, it is now appreciated that certain ligands can promote distinct receptor conformations and thereby bias signaling toward a specific pathway to differentially affect cell function. The recently deorphanized G protein-coupled receptor OGR1 [ovarian cancer G protein-coupled receptor 1 (GPR68)] exhibits diverse signaling events when stimulated by reductions in extracellular pH. We recently demonstrated airway smooth muscle cells transduce multiple signaling events, reflecting a diverse capacity to couple to multiple G proteins. Moreover, we recently discovered that the benzodiazepine lorazepam, more commonly recognized as anagonist of the gamma-aminobutyric acid A(GABA(A)) receptor, canfunctionas an allosteric modulator of OGR1 and, similarly, can promote multiple signaling events. In this study, we demonstrated that different benzodiazepines exhibit a range of biases for OGR1, with sulazepam selectively activating the canonical Gs of the G protein signaling pathway, in heterologous expression systems, as well as in several primary cell types. These findings highlight the potential power of biased ligand pharmacology for manipulating receptor signaling qualitatively, to preferentially activate pathways that are therapeutically beneficial.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available